| 英文别名 |
N-[3-[3-Cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]acetamide;Trametinib (GSK1120212);C26H23FIN5O4;GSK1120212;GSK-1120212;GSK1120212 (JTP-74057);N-[3-[3-cyclopropyl-5-(2-fluoro-4-iodoanilino)-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1-yl]phenyl]acetamide;N-[3-[3-Cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin...;N-[3-[3-Cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H);Trametinib;Trametinib (GSK1120212, GSK212, JTP-74057, Mekinist®);Trametinib-D4;Trametinib-D6;JTP74057;JTP-74057;Mekinist;GSK 1120212;JTP 74057;GSK212;Trametinib (GSK1120212JTP 74057);33E86K87QN;AK174783;N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl}phenyl)acetamide;N-[3-[3-Cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]acetamide (ACI);G 02442104;GSK 212;N-[3-[3-Cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl]acetamide;SNR 1611;NCGC00263180-07;N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-1H,2H,3H,4H,6H,7H-pyrido[4,3-d]pyrimidin-1-yl}phenyl)acetamide;s2673;Trametinib [USAN];TRAMETINIB [WHO-DD];HMS3295I05;SDCCGSBI-0646933.P001;SR-01000941589;D10175;AS-19382;MFCD17215075;NSC-758246;BRD-K12343256-001-01-4;GSK1120212 , JTP-74057;N-(3-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl)phenyl)acetamide;CHEBI:75998;GSK1120212 (Trametinib);HMS3656J11;SR-01000941589-1;CHEMBL2103875;NSC800956;CS-0060;LIRYPHYGHXZJBZ-UHFFFAOYSA-N;NCGC00263180-01;N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodophenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide;SCHEMBL170938;L01XE25;NSC-800956;UNII-33E86K87QN;CCG-264976;HY-10999;SW218089-2;MEK Inhibitor GSK1120212;TRAMETINIB [INN];DB08911;NCGC00263180-14;N-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxopyrido[3,4-e]pyrimidin-1-yl]phenyl]acetamide;J-523325;Acetamide, N-(3-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-3,4,6,7-tetrahydro-6,8- dimethyl-2,4,7-trioxopyrido(4,3-d)pyrimidin-1(2H)-yl)phenyl)-;TMT-212;TRAMETINIB [VANDF];BCP02307;BRD-K12343256-001-08-9;N-[3-[3-Cyclopropyl-5-[(2-Fluoro-4-Iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2h)-yl]phe nyl]acetamide;GTPL6495;AC-25891;TMT212;N-(3-{3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7- tetrahydropyrido(4,3-d)pyrimidin-1(2H)-yl}phenyl)acetamide;Q7833138;EX-5957;BRD-K12343256-00... |